Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Synlogic Inc (NQ: SYBX )

1.460 UNCHANGED
Streaming Delayed Price Updated: 3:54 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Synlogic Inc

< Previous 1 2 3 4 5 6 Next >
Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Announces International Nonproprietary Name Selection for SYNB1934
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum
From Synlogic, Inc.
Via GlobeNewswire
What 6 Analyst Ratings Have To Say About Synlogic
Via Benzinga
Synlogic: Q1 Earnings Insights
Via Benzinga
Synlogic Earnings Perspective: Return On Capital Employed
Via Benzinga
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
From Synlogic, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
From Synlogic, Inc.
Via GlobeNewswire
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. 
Via Benzinga
Synlogic to Present at the Jefferies Global Healthcare Conference
From Synlogic, Inc.
Via GlobeNewswire
3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year
These 3 penny stocks have 10X potential over the next twelve months, providing the right risk/reward bet for certain investors. 
Via InvestorPlace
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
From Synlogic, Inc.
Via GlobeNewswire
Why CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
Gainers Unique Fabricating, Inc. (NYSE: UFAB) gained 88.8% to $0.34 in pre-market trading after gaining around 4% on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday! 
Via InvestorPlace
Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria
From Synlogic, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
3 Megatrend Stocks to Buy for 10x Potential Returns
These megatrend stocks benefit from tailwinds provided by secular catalysts, but are also strong companies in their own right. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The 7 Best Biotech Stocks for Personalized Medicine Investors
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Philip Morris To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Thursday
Chardan Capital cut the price target for Synlogic, Inc. (NASDAQ: SYBX) from $7 to $5.5. Chardan Capital analyst Keay Nakae maintained a Buy rating. Synlogic shares gained 2.9% to close at $0.63 on... 
Via Benzinga
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria
From Synlogic, Inc.
Via GlobeNewswire
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
Presentations included full data from both the Phase 2 Synpheny-1 Study in phenylketonuria and Phase 1 Study for SYNB1353 as a potential treatment for homocystinuria 
From Synlogic, Inc.
Via GlobeNewswire
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Synlogic, Inc.
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 9th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.